Karyopharm Therapeutics Inc. · 5 hours ago
Principal Statistical Programmer
Maximize your interview chances
Health CareMedical
Comp. & BenefitsH1B Sponsor Likely
Insider Connection @Karyopharm Therapeutics Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Reviews and understands study documents, including the Protocol, electronic case Report Forms (eCRFs) and Statistical Analysis Plans (SAPs).
Reviews and understands raw eDTC database structure.
Participates in Statistical Analysis Plan (SAP) development and review.
Participates in TLF shells development and review.
Driver of Statistical Programming projects.
Major contributor to the development of Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) dataset specifications.
Leads projects in close partnership with Biostatisticians.
Develops global standard macros to improve the efficiency of the Statistical Programming Group.
Creates define.xml for regulatory submissions.
Uses CDISC validation software to ensure SDTM and ADaM datasets comply with regulations.
Oversees vendors for outsourced statistical programming work.
Mentors less experienced programmers.
Represents the Statistical Programming Group at cross functional team meetings.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
BS in Mathematics, Biostats/Statistics, Computer Science/Data Science or related field
8 – 12 years of Phase 1-Phase 3 clinical trials conducted in biotech/pharmaceutical/CRO environment experience
Expertise in SAS
Preferred
MS/PhD in Biostatistics/Statistics/CS/Data Science, Public Health or related field
Experience in Oncology therapeutic area
R or other statistical software
Experience in support of electronic submissions in electronic Common Technical Document (eCTD) format
Experience with Clinical Data Standards Consortium (CDISC) data standards SDTM and ADaM
Experience supporting an Integrated Summary of Safety (ISS) or Integrated Summary of Efficacy (ISE)
Company
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
H1B Sponsorship
Karyopharm Therapeutics Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (7)
2022 (6)
2021 (7)
2020 (15)
Funding
Current Stage
Public CompanyTotal Funding
$546.7MKey Investors
Avidity PartnersForesite CapitalDelphi Ventures
2022-12-05Post Ipo Equity· $165M
2020-03-02Post Ipo Equity· $172.5M
2014-06-30Post Ipo Equity· $111M
Recent News
2024-12-05
Company data provided by crunchbase